EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES)

Fabio Ynoe Moraes, Andre Guimaraes Gouveia, Gustavo Nader Marta, Mauricio Fraga da Silva, Ana Carolina Hamamura, Theodoros Tsakiridis, Michael Yan, Gustavo Arruda Viani

International Journal of Radiation Oncology*Biology*Physics · 2024-08 · 119 (5) · 1403-1412

DOI: 10.1016/j.ijrobp.2023.12.045 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024-08. Verfasst von Fabio Ynoe Moraes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Division of Radiation Oncology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada; Latin America Coope…. Hauptthemen laut MEDLINE: Radiosurgery, Bone Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The efficacy and safety of stereotactic body radiation therapy (SBRT) for patients with nonspine bone metastases remains in question. A systematic review and meta-analysis were performed to evaluate SBRT treatment outcomes in nonspine bone metastases. METHODS AND MATERIALS: Eligible studies were retrieved from MEDLINE, Embase, Scielo, the Cochrane Library, and annual meeting proceedings through July 6, 2023. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guideline recommendations. Quantitative synthesis was performed using a random-effects model. Meta-regression was performed to determine correlation between clinical and treatment factors with the local failure (LF) and fracture rate. P values ≤.05 were deemed statistically significant. RESULTS: Seven retrospective studies, with a total of 807 patients (1048 lesions) treated with SBRT were included, with median follow-up ranging from 7.6 to 26.5 months. The most common SBRT sites were pelvis (39.2%), ribs (25.8%), femur (16.7%), and humerus/shoulder region (8.7%). At 1 year, the LF and fracture rate were 7% (95% CI, 5.5%-8.5%; I2 = 0; n = 75/1048) and 5.3% (95% CI, 3%-7.5%; I2 = 0; n = 65/1010). The 2-year cumulative LF incidence was 12.1% (95% CI, 10%-15.5%). The overall survival and progression-free survival at 1 year were 82% (95% CI, 75%-88%; I2 = 82%; n = 746/867) and 33.5% (95% CI, 26%-41%; I2 = 0%; n = 51/152), with a median of 20.2 months (95% CI, 10.9-49.1 months) and 8.3 months (95% CI, 6.3-10.3 months) for overall survival and progression-free survival, respectively. Meta-regression analysis revealed a significant relationship between planning target volume and fracture rate (P < .05). Ribs (2.5%) followed by the femur (1.9%; 95% CI, 0%-6.1%) were the most common fracture sites. The occurrence of pain flare, fatigue, and dermatitis were 7%, 5.4%, and 0.65%, respectively. CONCLUSIONS: Stereotactic body radiation proves both safety and efficacy for non-spine bone metastases, and although serious complications (grade 3) are rare, one case of grade 5 complication was reported. Careful consideration of target volume is crucial due to its link with a higher fracture risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryBone NeoplasmsHumansTreatment OutcomeRetrospective Studies

Autor:innen und Institutionen

  • Department of Oncology, Division of Radiation Oncology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada; Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
  • Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Department of Oncology, Division of Radiation Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.
  • Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Radiation Oncology Department, Hospital Sirio Libanês, São Paulo, Brazil.
  • Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Radiation Oncology Department, Santa Maria Federal University, Rio Grande do Sul, Brazil.
  • Ribeirão Preto Medical School, Department of Medical Imagings, Hematology and Oncology of University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil.
  • Department of Oncology, Division of Radiation Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.

Zitieren

APA

Moraes, F. Y., Gouveia, A. G., Marta, G. N., da Silva, M. F., Hamamura, A. C., Tsakiridis, T., Yan, M., & Viani, G. A. (2024). Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES). International Journal of Radiation Oncology*Biology*Physics, 119(5), 1403-1412. https://doi.org/10.1016/j.ijrobp.2023.12.045

Vancouver

Moraes FY, Gouveia AG, Marta GN, da Silva MF, Hamamura AC, Tsakiridis T, et al. Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES). International Journal of Radiation Oncology*Biology*Physics. 2024;119(5):1403-1412. doi:10.1016/j.ijrobp.2023.12.045

BibTeX
@article{Moraes2024,
  author = {Moraes, Fabio Ynoe and Gouveia, Andre Guimaraes and Marta, Gustavo Nader and da Silva, Mauricio Fraga and Hamamura, Ana Carolina and Tsakiridis, Theodoros and Yan, Michael and Viani, Gustavo Arruda},
  title = {Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES)},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  volume = {119},
  number = {5},
  pages = {1403--1412},
  doi = {10.1016/j.ijrobp.2023.12.045}
}
Kostenlos starten →